Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Frilabiol Tonus
- Development stage
- Unknown
- Lead developer
- FRiLAB
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Frilabiol Tonus is an oral dietary supplement developed and marketed by the Swiss pharmaceutical company FRiLAB. It is part of the Frilabiol phytotherapy range, which is characterized by the use of innovative galenic formulations designed to provide safe, rapid action and a prolonged therapeutic effect. The product is specifically indicated for the management of physical and intellectual fatigue in adults and children over 12 years of age. As a phytotherapy product, it likely contains a blend of plant-derived active ingredients, although the specific composition is not detailed in the available company literature.
- Brand names
- Frilabiol Tonus
Beyond the preview
Go deeper on Frilabiol Tonus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Frilabiol Tonus.